The company is approved by Henan Economic system Reform Commission (1998) No. 38, with Zhengzhou Zhongsheng Industrial Group Co., Ltd. as the main sponsor. Henan Zhiyi Investment and Development Co., Ltd., Zhengzhou Zhulin Xianzhu washing products Co., Ltd., Zhengzhou Zhulin Refractory Co., Ltd., Gongyi Zhulin Xinhua Packaging material Factory and other five enterprises jointly initiated and established the joint stock co., Ltd. With the approval of document No. 98 issued by CSRC , the company issued 35 million public shares on August 13, 1999, with a total share capital of 136.14524 million yuan. The company's main business is drug manufacturing and drug R & D services, including pharmaceutical preparations, traditional Chinese medicine slices, drug R & D services and the circulation of pharmaceutical materials. The company's pharmaceutical preparation business is mainly oral preparation of traditional Chinese medicine, covering respiratory system, cardio-cerebrovascular, digestive system, nervous system and gynecological diseases. the main products include Shuanghuanglian oral liquid series, Shuanghuanglian mixture, Salvia miltiorrhiza oral liquid, Xiaoer Qingre Zhike oral liquid, children compound chicken inner gold chewable tablets, Huperzine A tablets and so on. Among them, Shuanghuanglian oral liquid (concentrated), Shuanghuanglian oral liquid (children's type), Shuanghuanglian mixture and children's compound chicken inner gold chewing tablets are the company's exclusive products. Enterprise honor: the all-China Federation of Industry and Commerce Pharmaceutical Chamber of Commerce awarded the company the honor of "Anti-epidemic Charity and Love", Henan High-tech Enterprises, "National High-tech industrialization demonstration Project", "excellent Enterprises in Zhengzhou" and so on.
Listing Date： 11/05/1999